vTitan Corp Announces Worldwide Availability of its Innovative Accuflow Thala Pump for Iron Chelation Therapy in Thalassemia Patients.

Chennai, India - September 15, 2025 - vTitan, a leading innovator and manufacturer of medical devices, today announced the worldwide availability of its state-of-the-art Thalassemia Pump, designed to transform the delivery of iron chelation therapy for patients living with Thalassemia and related blood disorders.

The AccuFlow Thala Pump was previously available in a limited release in India, where it has gained strong market confidence and patient trust, with over 700+ users across the country adopting the device for iron chelation therapy. vTitan has assiduously worked with Thalassemia societies across India and their patient base, constantly taking product feedback and improvising it to offer better ease of use. AccuFlow Thalassemia Pump has become the gold standard in its category for its reliable delivery, functionality, and ease of use for patients in the home setting.

Iron overload is a critical complication for patients requiring frequent blood transfusions, such as those with Thalassemia Major or sickle cell disease. Effective Iron chelation therapy is essential to prevent long-term damage to vital organs. AccuFlow Thala Pump addresses this need and is engineered to provide patients with a safe, reliable and comfortable solution for continuous infusion of chelation drugs, enabling better treatment adherence and quality of life.

Key Features of AccuFlow Thala Pump :

Portable and reliable - compact design with up to 40 hours of continuous operation on a single charge, enabling therapy at home or on the move.

Simple to use - a straightforward 3-step setup makes long hours of therapy less stressful for patients and caregivers.

Safe and dependable - equipped with visual and audio alarms for occlusion, syringe disengagement, low battery, and end-of-infusion alerts.

Trusted by families and doctors alike - making treatment less intimidating for patients, especially children.

Prasad Maganti, CEO of vTitan, said:
"Today marks an important milestone in our mission to empower Thalassemia patients with accessible, reliable, and affordable care. " said Prasad Maganti, CEO, vTitan Corp. "The worldwide launch of our Thalassemia pump means that patients across multiple geographical regions can benefit from affordable technology that benefits not just better disease management, but also improved quality of care. We are also actively looking to work with Thalassemia Communities worldwide to offer a seamless onboarding experience for end users and post sale support through a dedicated back end team"

End users and patient communities who wish to know more about the Accuflow Thala Pump can visit https://www.vtitan.com/thalassemia-syringepump to request a demo or explore purchase options.

Marketing Team
vTitan Corporation Private Limited,
Estancia IT Park, New Woodlands Block,
Plot No.140 & 151 , GST Road, Vallancherry Village,
Chengalpattu, 603202, Tamil Nadu, India.
Phone: +91 8807242689
Email: marketing@vtitan.com
Website: www.vtitan.com

vTitan is a MedTech company with a state-of-the-art design and manufacturing center in Chennai. The company specializes in the design, development, and manufacturing of cutting-edge medical devices that empower healthcare professionals and enhance the quality of life for patients worldwide. vTitan holds two patented technologies-one in infusion therapy and another in the radiology space-both aimed at delivering better quality treatment and improved patient outcomes.

This release was published on openPR.